AzTrials
AzTrials

Anesthetic Regional Techniques for Vaginal SurgeriesNCT04933500

Regional Anesthesia

An observational study of Anesthetic Regional Techniques for Vaginal Surgeries, run by Reham Ali Abdelhaleem Abdelrahman at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Both techniques are efficacious for sacral anesthesia during vaginal surgeries. Dural puncture epidural technique allows partial confirmation of epidural catheter placement. Read more about this study

Who is it for?
Ages 25 to 55 years, women onlyHealthy volunteers can take part
What is being tested?
Whitacre spinal needle
Type of treatment
Medical device
How many people
88 participants
Where
1 siteEgypt
Study dates
1 Jul 2021to 1 Dec 2022
How long will I take part?
6 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 55 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: adult female Egyptian patients

Who may be able to join

  • ASA I-II
  • --Age(25-55)years
  • Height(150-170cm)

Who cannot join

  • patient refusal
  • severe mitral or aortic stenosis

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Abdelrahman

    Cairo, 11562

Other trials in Egypt

About this study

Official title: Comparative Study Between Dural Puncture Epidural Technique and Conventional Epidural Technique During Elective Gynecological Vaginal Surgeries

Both techniques are efficacious for sacral anesthesia during vaginal surgeries. Dural puncture epidural technique allows partial confirmation of epidural catheter placement.

Being tested
Whitacre spinal needle

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Whitacre spinal needleDevice

    25G Whitacre spinal needle

Study groups in NCT04933500
Study groupRoleWhat they receive
Conventional epiduralepidural needle: Tuhoy needle 1.3mm (18 G) with 20G multi-orifice epidural catheter
Dural puncture epiduralepidural needle;Tuhoy needle 1.3mm (18G)with 20G multi-orifice epidural catheter and 25G Whitacre spinal needle
Receives: Device: Whitacre spinal needle

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Onset of bilateral sacral sensory loss

    sacral sensory loss is observed by needle brick

    Measured: 4months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2021
  2. Study start1 Jul 2021
  3. Primary completion1 Oct 2022
  4. Study completion1 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
88 participants (actual)
Target duration
6 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT04933500
Sponsor's protocol ID
AL-2021
Status last verified
Dec 2022
First submitted
16 Jun 2021
Last updated
15 Dec 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthetic Regional Techniques for Vaginal Surgeries, run by Reham Ali Abdelhaleem Abdelrahman at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Onset of bilateral sacral sensory loss (time frame: 4months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Dec 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in